Tag: Sinovac Biotech
Sinovac gets a shot in the arm
US law firm O’Melveny & Myers represented UBS Securities and Piper Jaffray as joint book-running managers in the US$66 million follow-on public offering of NASDAQ-listed Sinovac Biotech in February
LATEST ON VANTAGE ASIA
Knowing is half the battle
Sadaff Habib, an independent arbitrator based in Dubai, points out the major challenges in local arbitration and offers key tips for Chinese businesses
